Qiu-Yan Chen Selected Research

Nasopharyngeal Carcinoma

11/2022	Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
10/2022	Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
5/2022	The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study.
1/2022	Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive model.
1/2022	Construction and validation of a biochemical signature to predict the prognosis and the benefit of induction chemotherapy in patients with nasopharyngeal carcinoma.
1/2022	Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
1/2022	Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
1/2022	Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in locally recurrent nasopharyngeal carcinoma patients.
1/2022	Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
1/2022	Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiu-Yan Chen Research Topics

Disease

119	Nasopharyngeal Carcinoma 11/2022 - 04/2004
34	Neoplasms (Cancer) 05/2022 - 04/2004
34	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2011
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 02/2010
3	Mucositis 01/2020 - 02/2010
2	Disease Progression 12/2021 - 11/2015
2	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2018
2	Anemia 10/2021 - 01/2015
2	Bites and Stings (Sting) 07/2020 - 11/2019
2	Xerostomia 01/2020 - 01/2013
2	Necrosis 11/2019 - 01/2019
2	Stomatitis 10/2019 - 09/2013
2	Venous Thromboembolism 12/2018 - 01/2018
2	Neutropenia 12/2018 - 09/2013
1	Squamous Cell Carcinoma of Head and Neck 05/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Carcinoma (Carcinomatosis) 07/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Trismus (Lockjaw) 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Dermatitis 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Epstein-Barr Virus Infections 10/2019
1	Pain (Aches) 10/2019
1	Lymphadenopathy 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018
1	Leukopenia 12/2018
1	Nausea 01/2018
1	Vomiting 01/2018
1	Anorexia 01/2018
1	Ototoxicity 01/2018
1	Exanthema (Rash) 08/2017

Drug/Important Bio-Agent (IBA)

34	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 08/2013
18	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 02/2010
7	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 04/2004
4	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2004
4	Biological ProductsIBA 05/2021 - 11/2011
4	Interleukin-6 (Interleukin 6)IBA 07/2020 - 10/2012
4	Docetaxel (Taxotere)FDA Link 01/2020 - 02/2010
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 12/2007
3	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 11/2022 - 01/2016
3	Gemcitabine FDA Link 01/2022 - 01/2020
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021 - 08/2013
3	CytokinesIBA 07/2020 - 10/2012
3	Viral DNAIBA 01/2019 - 11/2015
3	Indicators and Reagents (Reagents)IBA 12/2015 - 06/2011
2	toripalimabIBA 01/2022 - 01/2021
2	nedaplatinIBA 12/2021 - 01/2018
2	EnzymesIBA 10/2021 - 02/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2018
2	ChemokinesIBA 01/2020 - 12/2007
2	Cetuximab (Erbitux)FDA Link 01/2019 - 08/2017
2	C-Reactive ProteinIBA 07/2018 - 02/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2017 - 12/2007
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2015 - 08/2014
2	Endothelin A ReceptorIBA 08/2013 - 04/2011
2	Pharmaceutical PreparationsIBA 01/2013 - 02/2010
2	Carboplatin (JM8)FDA LinkGeneric 10/2012 - 02/2010
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	angiogeninIBA 01/2021
1	CarbohydratesIBA 07/2020
1	HLA-DR Antigens (HLA-DR)IBA 07/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	LigandsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	InterferonsIBA 11/2019
1	Antiviral Agents (Antivirals)IBA 11/2019
1	Immune Checkpoint InhibitorsIBA 10/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2019
1	Zoledronic Acid (Zometa)FDA Link 10/2019
1	nimotuzumabIBA 01/2019
1	nitazoxanide (NTZ)FDA Link 01/2019
1	AnticoagulantsIBA 12/2018
1	Taxoids (Taxanes)IBA 12/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 07/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2017
1	InflammasomesIBA 07/2017
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 02/2016

Therapy/Procedure

40	Radiotherapy 11/2022 - 04/2004
33	Chemoradiotherapy 10/2022 - 10/2009
28	Drug Therapy (Chemotherapy) 11/2022 - 02/2010
21	Induction Chemotherapy 01/2022 - 10/2009
15	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2021 - 01/2013
11	Therapeutics 05/2022 - 12/2011
6	Neoadjuvant Therapy 01/2019 - 02/2010
4	Immunotherapy 01/2020 - 02/2015
3	Re-Irradiation 01/2020 - 07/2007
3	Aftercare (After-Treatment) 10/2019 - 05/2007
3	Catheters 12/2018 - 05/2007
2	Adjuvant Chemotherapy 12/2021 - 01/2019
2	Salvage Therapy 01/2020 - 10/2012
2	Neck Dissection (Radical Neck Dissection) 01/2019 - 01/2018
1	TP protocol 01/2022
1	Maintenance Chemotherapy 11/2021